title: Utility of CSF in translational neuroscience.
abstract: Human cerebrospinal fluid (CSF) sampling is of high value as the only general applicable methodology to obtain information on free drug concentrations in individual human brain. As the ultimate interest is in the free drug concentration at the CNS target site, the question is what CSF concentrations may tell us in that respect. Studies have been performed in rats and other animals for which concentrations in brain extracellular fluid (brain ECF) as a target site for many drugs, have been compared to (cisterna magna) CSF concentrations, at presumed steady state conditions,. The data indicated that CSF drug concentrations provided a rather good indication of, but not a reliable measure for predicting brain ECF concentrations. Furthermore, comparing rat with human CSF concentrations, human CSF concentrations tend to be higher and display much more variability. However, this comparison of CSF concentrations cannot be a direct one, as humans probably had a disease for which CSF was collected in the first place, while the rats were healthy. In order to be able to more accurately predict human brain ECF concentrations, understanding of the complexity of the CNS in terms of intrabrain pharmacokinetic relationships and the influence of CNS disorders on brain pharmacokinetics needs to be increased. This can be achieved by expanding a currently existing preclinically derived physiologically based pharmacokinetic model for brain distribution. This model has been shown to successfully predict data obtained for human lumbar CSF concentrations of acetaminophen which renders trust in the model prediction of human brain ECF concentrations. This model should further evolute by inclusion of influences of drug properties, fluid flows, transporter functionalities and different disease conditions. Finally the model should include measures of target site engagement and CNS effects, to ultimately learn about concentrations that best predict particular target site concentrations, via human CSF concentrations.
authors: Leiden-Amsterdam Center for Drug Research, Leiden, The Netherlands. l.lange@lacdr.leidenuniv.nl
authors: Elizabeth C M
authors: EC
authors: de Lange
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology; D001921:Brain / Q000033:anatomy & histology / Q000098:blood supply / Q000378:metabolism* / Q000502:physiology; D002491:Central Nervous System Agents / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics; D002560:Cerebrovascular Circulation; D055808:Drug Discovery / Q000379:methods*; D045604:Extracellular Fluid / Q000737:chemistry; D006801:Humans; D017551:Microdialysis; D008959:Models, Neurological; D009488:Neurosciences / Q000379:methods*; D013045:Species Specificity; D014018:Tissue Distribution
chemical_list: D002491:Central Nervous System Agents
references: J Pharm Sci. 2011 Sep;100(9):3577-93
references: 21544824
references: Curr Drug Metab. 2008 Jan;9(1):46-59
references: 18220571
references: Epilepsia. 2006 Apr;47(4):681-94
references: 16650134
references: Neurology. 1994 Aug;44(8):1469-72
references: 8058151
references: Brain Res. 2009 Jan 12;1248:127-35
references: 19007752
references: J Pharmacol Exp Ther. 2011 Dec;339(3):935-44
references: 21934030
references: Drug Metab Dispos. 2012 May;40(5):877-83
references: 22287668
references: Am J Physiol. 1977 Mar;232(3):R73-9
references: 842696
references: Cancer Chemother Pharmacol. 2010 Apr;65(5):817-24
references: 19662415
references: Pharm Res. 1995 Dec;12(12):1838-44
references: 8786954
references: Stroke. 1977 May-Jun;8(3):346-51
references: 860292
references: Brain Res. 2011 May 16;1390:142-9
references: 21435335
references: J Neurosci Methods. 1991 Nov;40(1):31-8
references: 1795551
references: Am J Physiol. 1965 Dec;209(6):1219-26
references: 5846924
references: J Cereb Blood Flow Metab. 2006 Sep;26(9):1165-75
references: 16395287
references: Curr Top Med Chem. 2009;9(2):148-62
references: 19200002
references: Neuroscience. 2004;129(4):851-60
references: 15561403
references: Seizure. 2003 Sep;12(6):330-6
references: 12915078
references: J Pharmacol Exp Ther. 2005 Jun;313(3):1254-62
references: 15743928
references: Ann Nucl Med. 2006 Feb;20(2):131-8
references: 16615422
references: J Clin Endocrinol Metab. 1991 Apr;72(4):819-23
references: 2005207
references: NeuroRx. 2005 Oct;2(4):671-82
references: 16489374
references: Antimicrob Agents Chemother. 1995 Dec;39(12):2728-31
references: 8593009
references: Acta Anaesthesiol Scand. 2001 Mar;45(3):390-2
references: 11207479
references: Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):337-44
references: 20102287
references: Neurobiol Dis. 2010 Jan;37(1):33-7
references: 19664709
references: J Pharmacol Exp Ther. 1991 Nov;259(2):620-5
references: 1941610
references: J Pharm Sci. 2005 Jul;94(7):1577-88
references: 15920773
references: Br J Pharmacol. 1999 Oct;128(4):917-24
references: 10556926
references: J Pharmacokinet Biopharm. 1985 Aug;13(4):425-40
references: 4087170
references: Sci Transl Med. 2012 Aug 15;4(147):147ra111
references: 22896675
references: J Med Chem. 2009 Oct 22;52(20):6233-43
references: 19764786
references: Am J Physiol. 1981 Apr;240(4):F319-28
references: 7223889
references: J Pharm Sci. 1995 Jul;84(7):871-6
references: 7562440
references: Biopharm Drug Dispos. 2002 Dec;23(9):351-60
references: 12469328
references: Pharm Res. 2004 Aug;21(8):1313-30
references: 15359566
references: Drug Metab Dispos. 2007 Aug;35(8):1341-9
references: 17470526
references: Prog Brain Res. 2007;162:459-78
references: 17645933
references: Pharm Res. 1998 Nov;15(11):1657-65
references: 9833984
references: Xenobiotica. 2012 Mar;42(3):256-65
references: 22017605
references: Br J Pharmacol. 2000 May;130(2):242-8
references: 10807660
references: J Pharmacol Exp Ther. 1984 Apr;229(1):44-50
references: 6707947
references: J Antimicrob Chemother. 2008 Jun;61(6):1328-31
references: 18353805
references: Adv Drug Deliv Rev. 2004 Oct 14;56(12):1825-57
references: 15381336
references: Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):215-20
references: 20050843
references: J Pharmacol Exp Ther. 1996 Jun;277(3):1550-9
references: 8667222
references: Adv Drug Deliv Rev. 2004 Oct 14;56(12):1793-809
references: 15381334
references: J Pharm Sci. 2008 Aug;97(8):3433-41
references: 17990306
references: Drug Metab Dispos. 2009 Apr;37(4):787-93
references: 19116265
references: Clin Pharmacokinet. 1982 Jul-Aug;7(4):312-35
references: 6749368
references: Antimicrob Agents Chemother. 2012 Feb;56(2):979-88
references: 22106225
references: Arch Dis Child. 1973 Oct;48(10):757-67
references: 4796010
references: Cerebrospinal Fluid Res. 2008 May 14;5:10
references: 18479516
references: Seizure. 2004 Dec;13(8):574-81
references: 15519917
references: Fluids Barriers CNS. 2013 Feb 22;10(1):12
references: 23432852
references: Brain Res. 1995 Dec 8;702(1-2):261-5
references: 8846086
references: Anal Chem. 1993 Apr 15;65(8):1017-22
references: 8494171
references: Drug Metab Dispos. 2006 Jun;34(6):955-60
references: 16510542
references: Br J Clin Pharmacol. 1992 Jul;34(1):79-81
references: 1633071
references: J Pharmacol Exp Ther. 1993 Feb;264(2):899-909
references: 8437131
references: Brain Res. 1973 Mar 30;52:323-32
references: 4739806
references: AAPS J. 2005 Oct 07;7(3):E532-43
references: 16353931
references: Curr Med Chem. 2007;14(14):1525-37
references: 17584061
references: J Pharmacol Exp Ther. 1997 Oct;283(1):293-304
references: 9336336
references: J Neurooncol. 2010 Mar;97(1):25-32
references: 19688296
references: Neuroscience. 2004;129(4):957-70
references: 15561411
references: J Neurosurg Spine. 2012 Apr;16(4):394-401
references: 22243405
references: Drug Metab Dispos. 2009 Apr;37(4):753-60
references: 19158315
references: Life Sci. 2000 Mar 31;66(19):1805-16
references: 10809178
references: Curr Opin Crit Care. 2006 Apr;12(2):112-8
references: 16543785
references: J Pharmacol Exp Ther. 1997 Feb;280(2):551-60
references: 9023263
references: Epilepsia. 2001 Feb;42(2):256-61
references: 11240599
references: Clin Microbiol Rev. 2010 Oct;23(4):858-83
references: 20930076
references: Life Sci. 1990;46(2):105-19
references: 2299972
references: Br J Clin Pharmacol. 2004 Apr;57(4):427-35
references: 15025740
references: Neurochem Int. 2004 Sep;45(4):545-52
references: 15186921
references: Rev Neurol (Paris). 2009 Dec;165(12):1029-38
references: 19913860
references: Pharm Res. 1997 Jul;14(7):865-72
references: 9244142
references: Clin Pharmacokinet. 2002;41(10):691-703
references: 12162757
references: Int J Antimicrob Agents. 2012 Apr;39(4):343-5
references: 22325119
references: Pharm Res. 1994 Sep;11(9):1223-32
references: 7816748
references: Pharm Res. 2008 Aug;25(8):1737-50
references: 18058202
references: Drug Metab Dispos. 2009 Jan;37(1):137-42
references: 18936112
references: Br J Anaesth. 2006 Jul;97(1):18-25
references: 16698861
references: Drug Metab Dispos. 2007 Sep;35(9):1711-9
references: 17591680
references: AAPS J. 2012 Sep;14(3):543-53
references: 22588644